Diagnosis: Post-transplant cutaneous squamous cell carcinoma
A 65-year-old male renal transplant recipient presents with multiple hyperkeratotic tumors on his forearms, which have progressively increased in number and size over the past year. Given his immunosuppressed state, these lesions raise concern for malignancy, particularly in the context of his transplant history and prolonged immunosuppressive therapy.
A 65-year-old male with a history of renal transplantation for end-stage renal disease presents with multiple hyperkeratotic tumors on both forearms. The lesions have been present for approximately one year and have progressively enlarged. On examination, the patient exhibits several rough, scaly plaques and nodules, some with central ulceration.Multiple lesions: Numerous hyperkeratotic tumors noted bilaterally on forearms.Size and texture: Ranging from 0.5 to 3 cm, some lesions are crusted and ulcerated.Asymptomatic: No associated pain, pruritus, or drainage.Dermatological history: Previous history of sun exposure and actinic keratoses.Immunosuppression: On chronic immunosuppressive therapy post-transplantation.
The patient reports that the lesions began as small, rough patches that gradually enlarged over the past year. He has a significant history of sun exposure and previously treated actinic keratoses. His immunosuppressive regimen includes tacrolimus and mycophenolate mofetil, which he has been on for over five years. There are no significant family histories of skin cancer. He denies any new medications or changes in lifestyle that could have triggered the lesions.Onset: Lesions have been present for approximately one year.Prior treatments: No previous interventions for the current lesions.Immunosuppressive therapy: Tacrolimus and mycophenolate mofetil for renal transplant.Sun exposure: Significant history of sun exposure due to outdoor occupation.Family history: No family history of skin cancer.
Acute / First-Line ManagementConsider surgical excision for localized lesions, particularly those showing signs of malignancy.Topical chemotherapy with 5-fluorouracil (5-FU) 5% cream applied BID for 3-4 weeks may be beneficial for superficial lesions.Cryotherapy can be utilized for isolated lesions, particularly if excision is not feasible.Workup and Diagnostic ConfirmationSkin biopsy of representative lesions is essential for histopathological confirmation.Consider imaging studies (e.g., ultrasound or CT) if there is concern for deeper invasion or metastasis.Regular dermatologic follow-up for monitoring of new lesions and potential recurrence.Long-Term ManagementRegular skin examinations every 6-12 months are recommended for early detection of new skin cancers.Education on sun protection measures, including daily use of broad-spectrum sunscreen (SPF 30 or higher).Consideration of dose adjustment or modification of immunosuppressive therapy based on the skin cancer risk profile.
Actinic Keratosis: Common in immunosuppressed patients, presents as rough, scaly patches due to sun damage, but typically does not form nodules.Keratoacanthoma: Rapidly growing, dome-shaped nodules that may mimic squamous cell carcinoma; often self-resolving.Basal Cell Carcinoma: Common skin cancer in sun-exposed areas, typically appears as pearly nodules or ulcerated lesions.Cutaneous Lymphoma: May present with plaques or tumors, often with a background of pruritus and other systemic symptoms.Malignant Melanoma: Less common but critical to consider; usually presents as an irregularly pigmented lesion with asymmetry.Paget's Disease of the Nipple: Rare; presents as eczematous changes in the nipple area, but can occur elsewhere; often associated with underlying malignancy.Invasive Squamous Cell Carcinoma: Characterized by indurated, ulcerated lesions; common in immunosuppressed patients.Porokeratosis: Presents as annular plaques with a keratotic border; associated with immunosuppression but less common.
High-Yield PearlsImmunosuppression: Patients on immunosuppressive therapy post-transplant are at significantly increased risk for skin cancers, particularly squamous cell carcinoma.Regular Screening: Routine skin examinations are critical for early detection and management of skin malignancies in high-risk populations.Sun Protection: Daily use of sunscreen and protective clothing is essential in preventing nonmelanoma skin cancers in susceptible individuals.Histological Confirmation: Biopsy of suspicious lesions is necessary for definitive diagnosis and appropriate management.Therapeutic Options: Surgical excision, topical chemotherapy, and cryotherapy are effective treatment options for cutaneous malignancies.Immunosuppressed patients require vigilant dermatologic surveillance to mitigate the risk of cutaneous malignancies.
Tags: transplant SCC, immunosuppressed